1. Home
  2. CETX vs CYCC Comparison

CETX vs CYCC Comparison

Compare CETX & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CETX
  • CYCC
  • Stock Information
  • Founded
  • CETX 1998
  • CYCC 1992
  • Country
  • CETX United States
  • CYCC United States
  • Employees
  • CETX N/A
  • CYCC N/A
  • Industry
  • CETX EDP Services
  • CYCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • CETX Technology
  • CYCC Health Care
  • Exchange
  • CETX Nasdaq
  • CYCC Nasdaq
  • Market Cap
  • CETX 4.3M
  • CYCC 3.6M
  • IPO Year
  • CETX 1998
  • CYCC N/A
  • Fundamental
  • Price
  • CETX $2.04
  • CYCC $0.34
  • Analyst Decision
  • CETX
  • CYCC Strong Buy
  • Analyst Count
  • CETX 0
  • CYCC 1
  • Target Price
  • CETX N/A
  • CYCC $11.00
  • AVG Volume (30 Days)
  • CETX 216.1K
  • CYCC 404.4K
  • Earning Date
  • CETX 02-14-2025
  • CYCC 03-18-2025
  • Dividend Yield
  • CETX N/A
  • CYCC N/A
  • EPS Growth
  • CETX N/A
  • CYCC N/A
  • EPS
  • CETX N/A
  • CYCC N/A
  • Revenue
  • CETX $63,725,617.00
  • CYCC $74,000.00
  • Revenue This Year
  • CETX $19.77
  • CYCC N/A
  • Revenue Next Year
  • CETX $15.00
  • CYCC $88.68
  • P/E Ratio
  • CETX N/A
  • CYCC N/A
  • Revenue Growth
  • CETX N/A
  • CYCC N/A
  • 52 Week Low
  • CETX $1.80
  • CYCC $0.30
  • 52 Week High
  • CETX $12,096.00
  • CYCC $4.00
  • Technical
  • Relative Strength Index (RSI)
  • CETX 24.88
  • CYCC 46.57
  • Support Level
  • CETX $1.80
  • CYCC $0.32
  • Resistance Level
  • CETX $2.59
  • CYCC $0.38
  • Average True Range (ATR)
  • CETX 0.17
  • CYCC 0.02
  • MACD
  • CETX 0.10
  • CYCC 0.00
  • Stochastic Oscillator
  • CETX 30.38
  • CYCC 50.00

About CETX Cemtrex Inc.

Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes, Security segment, Industrial Services segment and the corporate segment. The security segment provides end to end security to all industrial, corporate and governmental security via owned subsidiary Vicon. Whereas AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment. It geographically operates in USA, UK and India, with maximum of revenue from USA.

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.

Share on Social Networks: